title: In vivo tumor imaging in mice with near-infrared labeled endostatin.
abstract: Endostatin is a potent inhibitor of angiogenesis currently in phase I clinical trials. Imaging technologies that use near-infrared fluorescent probes are well suited to the laboratory setting. The goal of this study was to determine whether endostatin labeled with a near-infrared probe (Cy5.5) could be detected in an animal and whether it would selectively localize to a tumor. Endostatin was conjugated to Cy5.5 monofunctional dye and injected into mice bearing Lewis lung carcinoma tumors (350 mm2). Mice were imaged at various time points while under sedation using a lightproof box affixed to a fluorescent microscope mounted with a filter in the near-infrared bandwidth consistent with Cy5.5 fluorescence. After i.p. injection, endostatin-Cy5.5 was absorbed producing a near-infrared fluorescent image within the tumors at 18 h reaching a maximum at 42 h after injection. No signal was emitted from mice injected with unlabeled endostatin or Cy5.5 dye alone or those that received no injection. Further results show that a dose response exists with injection of endostatin-Cy5.5. Mimicking the clinical route of administration, an i.v. injection had a peak signal emission at 3 h but also persisted to 72 h. Finally, to determine the intratumoral binding site for endostatin, we performed immunofluorescence on tumor specimens and demonstrated that endostatin binds to tumor vasculature and colocalizes with platelet/endothelial cell adhesion molecule 1 expression. This study demonstrates that endostatin covalently bound to Cy5.5 will migrate from a distant i.p. injection site to a tumor. These data indicate that endostatin-Cy5.5 is appropriate for selectively imaging tumors in uninjured experimental animals.
authors.affiliation: Imaging and Molecular Therapeutics Section, Radiation Oncology Branch, National Cancer Institute, Bethesda, MD 20892, USA.
authors.forename: Deborah
authors.initials: D
authors.lastname: Citrin
authors.forename: Andrew K
authors.initials: AK
authors.lastname: Lee
authors.forename: Tamalee
authors.initials: T
authors.lastname: Scott
authors.forename: Mary
authors.initials: M
authors.lastname: Sproull
authors.forename: Cynthia
authors.initials: C
authors.lastname: Ménard
authors.forename: Philip J
authors.initials: PJ
authors.lastname: Tofilon
authors.forename: Kevin
authors.initials: K
authors.lastname: Camphausen
mesh_terms: D000818:Animals; D002232:Carbocyanines / Q000032:analysis; D045744:Cell Line, Tumor; D043169:Endostatins / Q000008:administration & dosage / Q000032:analysis* / Q000378:metabolism / Q000493:pharmacokinetics; D005240:Feasibility Studies; D005456:Fluorescent Dyes / Q000032:analysis; D007259:Infrared Rays; D008297:Male; D051379:Mice; D008810:Mice, Inbred C57BL; D008856:Microscopy, Fluorescence; D009368:Neoplasm Transplantation; D009369:Neoplasms / Q000378:metabolism; D019408:Platelet Endothelial Cell Adhesion Molecule-1 / Q000032:analysis
chemical_list: C098793:CY5.5 cyanine dye; D002232:Carbocyanines; D043169:Endostatins; D005456:Fluorescent Dyes; D019408:Platelet Endothelial Cell Adhesion Molecule-1